Arterial hypertension (AH) is a common chronic disease characterized by a persistent increase in blood pressure. In addition to the main mechanisms of hypertension development, including activation of the sympathetic nervous system, disruption of the renin-angiotensin-aldosterone cascade, endothelial dysfunction, increased vascular reactivity, and vascular remodeling, it is assumed that inflammation is also involved in the formation of the disease. The review considers the involvement of cytokines in the pathogenesis of AH, as well as their interaction with blood pressure regulatory systems.

Arterial hypertension, inflammation, cytokines

Alexander BT, Massey MB, Cockrell KL, Bennett WA, and Granger JP. Elevations in plasma TNF in pregnant rats decreases renal nNOS and iNOS and results in hypertension // Am J Hypertens. - 2002. - No. 15. - R. 170-175.

C. Chrysohoou, C. Pitsavos, DB Panagiotakos, J. Skoumas, and C. Stefanadis, “Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA Study,” // The American Journal of Hypertension. - 2004. - vol. 17. - No. 7. - R. 568-573.

C. Stumpf, J. Jukic, A. Yilmaz et al., “Elevated VEGF-plasma levels in young patients with mild essential hypertension,” // European Journal of Clinical Investigation. - 2009. - vol. 39. - No. 1. - R. 31-36.

CU Chae, RT Lee, N. Rifai, and PM Ridker. “Blood pressure and inflammation in apparently healthy men” // Hypertension. - 2001. - vol. 38. - No. 3. - R. 399–403.

DG Harrison, TJ Guzik, HE Lob, MS Madhur, PJ Marvar, SR Thabet, A. Vinh, CM Weyand. Inflammation, Immunity, and Hypertension // Hypertension. - 2011. - 57. - R. 132-140.

Didion SP, Kinzenbaw DA, Schrader LI, Chu Y, Faraci FM. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction // Hypertension. - 2009. - 54. - R. 619 - 624.

Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats // Am J Physiol Regul Integr Comp Physiol. - 2008. - 294. - R. 76-83.

Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4CD25regulatory T cells // Nat Immunol. - 2003. - No. 4. - R. 330 -336.

G. Yan, B. You, S. Chen, JK Liao, and J. Sun, “Tumor necrosis factor- downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-1,” // Circulation Research. - 2008. - vol. 103. - No. 6. - R. 591-597.

H. Nguyen, VL Chiasson, P. Chatterjee, SE Kopriva, KJ Young, and BM Mitchell, “Interleukin-17 causes Rho-kinasemediated endothelial dysfunction and hypertension,” // Cardiovascular Research. - 2013. - vol. 97. - No. 4. - R. 696-704.

H. Tomita, K. Egashira, M. Kubo-Inoue et al., “Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels,” // Arteriosclerosis, Thrombosis, and Vascular Biology. - vol. 18. - No. 9. - R. 1456-1464.

Hartupee J, Liu C, Novotny M, Li X, Hamilton T. IL-17 enhances chemokine gene expression through mRNA stabilization // J Immunol. - 2007. - 179. - R. 4135-4141.

Joey P. Granger. An emerging role for inflammatory cytokines in hypertension // American Journal of Physiology - Heart and Circulatory Physiology Published. - 2006. - Vol. 290. - No. 3. - R. 48-54.

Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of saltsensitive hypertension // N Engl J Med. - 2002. - 346. - R. 913-923.

KM Maki-Petaja, FC Hall, AD Booth et al., “Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor- therapy,” // Circulation. - 2006. - vol. 114. - No. 11. - R. 1185-1192.

Katherine T. Mills, Joshua D. Bundy, Tanika N. Kelly et al. Global Disparities of Hypertension Prevalence and Control. A Systematic Analysis of Population-Based Studies From 90 Countries // Circulation. - 2016. - 134. - R. 441-450.

Kvakan H, Kleinewietfeld M, Qadri F, Park JK, Fischer R, Schwarz I, Rahn HP, Plehm R, Wellner M, Elitok S, Gratze P, Dechend R, Luft FC, Muller DN. Regulatory T cells ameliorate angiotensin II-induced cardiac damage // Circulation. - 2009. - 119. - R. 2904 -2912.

LE Bautista, JE Atwood, PG O'Malley, and AJ Taylor, “Association between C-reactive protein and hypertension in healthy middle-aged men and women,” // Coronary Artery Disease. - 2004. - vol. 15. - No. 6. - R.331-336.

LE Bautista, LM Vera, IA Arenas, and G. Gamarra, “Independent association between inflammatory markers (Creactive protein, interleukin-6, and TNF-alpha) and essential hypertension,” // Journal of Human Hypertension. - 2005. - vol. 19. - №2. - R. 149-154.

LaMarca BBD, Bennett WA, Alexander BT, Cockrell K, and Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-α // Hypertension. - 2005. - 46. - Р.1022–1025.

Lee DL, Sturgis LC, Labazi H, Osborne JB Jr, Fleming C, Pollock JS, Manhiani M, Imig JD, and Brands MW. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice // Am J Physiol Heart Circ Physiol. - 2006. - 290. - R. 935–940.

Muller DN, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Hampich F, Fiebeler A, Ju X, Finckenberg P, Theuer J, Viedt C, Kreuzer J, Heidecke H, Haller H, Zenke M, Luft FC. Immunosuppressive treatment protects against angiotensin II-induced renal damage // Am J Pathol. - 2002. - 161. - R. 1679 -1693.

Orshal JM and Khalil R.A. Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats // Hypertension. - 2004. - 43. - R. 434-444.

P. Kubes, M. Suzuki, and DN Granger, “Nitric oxide: an endogenous modulator of leukocyte adhesion,” // Proceedings of the National Academy of Sciences of the United States of America. - 1991. - vol. 88. - No. 11. - R. 4651-4655.

Quynh N. Dinh, Grant R. Drummond, Christopher G. Sobey, and Sophocles chrissobolis.Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension // BioMed Research International. - 2014. - Volume 3. - R. 11-18.

RF Mortensen and W. Zhong, “Regulation of phagocytic leukocyte activities by C-reactive protein,” Journal of Leukocyte Biology. - 2000. - Vol. 67. - No. 4. - R. 495-500.

Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, and Egido J. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney // Kidney Int. - 2002. - No. 82. - R. 12-22.

S. Chrissobolis and FM Faraci, “The role of oxidative stress and NADPH oxidase in cerebrovascular disease,” Trends in Molecular Medicine. - 2008. - vol. 14. - No. 11. -R. 495–502.

Ахмедов А.Т., Особенности иммунной системы при врожденных пороков сердца, // EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE. – 2022. Vol. 2 No. 3 EJMMP. – С. 35-40. [Akhmedov A. T., Features of the immune system in congenital heart defects, // EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE. – 2022. Vol. 2 no. 3 EJMMP. – pp. 35-40 [in Russian]

S. Oparil, M.A. Zaman, D.A. Calhoun. Pathogenesis of Hypertension // Ann Intern Med. - 2003. - 139. - R. 761-776. 4 Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension // Cell. - 2001. -104. - R. 545-556.

S. Verma, C. Wang, S. Li et al., “A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis,” // Circulation. - 2002. - vol. 106. - No. 8. - R. 913-919.

S. Zhao, Q. Li, L. Liu, Z. Xu, and J. Xiao, “Simvastatin reduces interleukin-1beta secretion by peripheral blood mononuclear cells in patients with essential hypertension,” Clinica Chimica Acta. - vol. 344. - No. 1. - R. 195-200.

Ахмедов А.Т., Сравнительная оценка иммунологических параметров лабораторных животных аутоимплантации тимуса в динамике наблюдения, // EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE. – 2022. - Vol. 2 No. 3: EJMMP. C. 40-45 [Akhmedov A. T., Comparative evaluation of the immunological parameters of laboratory animals after thymus autoimplantation in the dynamics of observation, // EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE. - 2022. - Vol. 2 no. 3: EJMMP. C. 40-45 in Russian]

Sanz-Rosa D, Oubina MP, Cediel E, De Las Heras N, Vegazo O, Jimenez J, Lahera V, and Cachofeiro V. Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NFκB/IκB system / / Am J Physiol Heart Circ Physiol. - 2005. - 288. - R. 111-115.

Sturgis LC, Cannon JG, Schreihofer DA, Brands MW. The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6 // Am J Physiol Regul Integr Comp Physiol. - 2009. - 297. - R. 1742-1748.

Tran LT, MacLeod KM, McNeill JH. Chronic etanercept treatmentprevents the development of hypertension in fructose-fed rats // Mol Cell Biochem. - 2009. - 330. - R. 219 -228.

V. Pasceri, JT Willerson, and ETH Yeh, “Direct proinflammatory effect of C-reactive protein on human endothelial cells,” // Circulation. - 2000. - Vol. 102. - No. 18. - R. 2165–2168.

Venegas-Pont M, Manigrasso MB, Grifoni SC, LaMarca BB, Maric C, Racusen LC, Glover PH, Jones AV, Drummond HA, Ryan MJ. Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus // Hypertension. - 2010. - 56. - R. 643-649.

Ахмедов А.Т., Особенности иммунной системы при врожденных пороков сердца, // EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE. – 2022. Vol. 2 No. 3 EJMMP. – С. 35-40. [Akhmedov A. T., Features of the immune system in congenital heart defects, // EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE. – 2022. Vol. 2 no. 3 EJMMP. – pp. 35-40 [in Russian]

Witowski J, Ksiazek K, Jorres A. Interleukin-17: a mediator of inflammatory responses // Cell Mol Life Sci. - 2004. - No. 61. - R. 567-579.

World Health Organization World Health Report 2002: Reducing Risks, Promoting Healthy Life. - Geneva: 2002. - 516 rubles.

X. Yu, Z. Yang, and M. Yu, “Correlation of tumor necrosis factor alpha and interleukin 6 with hypertensive renal damage,” // Renal Failure. - vol. 32. - No. 4. - R. 475–479.

Zhang ZH, Wei SG, Francis J, and Felder RB. Cardiovascular and renal sympathetic activation by blood-borne TNF in rat: the role of central prostaglandins // Am J Physiol Regul Integr Comp Physiol. - 2003. - 284. - R. 916-927.

Obidovna, D. Z., & Sulaymonovich, D. S. (2022). Physical activity and its impact on human health and longevity. Достижения науки и образования, (2 (82)), 120-126.

Obidovna, D. Z., & Sulaymonovich, D. S. (2022). THE CONCEPT OF" HEALTHY LIFESTYLE" IN PSYCHOLOGICAL RESEARCH. ResearchJet Journal of Analysis and Inventions, 3(06), 53-64.

Obidovna, D. Z., & Sulaimonovich, D. S. (2023). Influence of the Mode of Work and Recreation of the Student's Health. INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES, 2(3), 3-5.

Obidovna, D. Z., & Sulaymonovich, D. S. (2023). Forming a Healthy Lifestyle for Students on the Example of the Volleyball Section in Universities. EUROPEAN JOURNAL OF INNOVATION IN NONFORMAL EDUCATION, 3(3), 22-25.